Hollema H - Search Results

1

Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.

van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ. van Geelen CM, et al. Among authors: hollema h. J Clin Oncol. 2006 Nov 1;24(31):4998-5004. doi: 10.1200/JCO.2006.06.8809. J Clin Oncol. 2006. PMID: 17075118

2

Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.

Berends MJ, Wu Y, Sijmons RH, Mensink RG, van der Sluis T, Hordijk-Hos JM, de Vries EG, Hollema H, Karrenbeld A, Buys CH, van der Zee AG, Hofstra RM, Kleibeuker JH. Berends MJ, et al. Among authors: hollema h. Am J Hum Genet. 2002 Jan;70(1):26-37. doi: 10.1086/337944. Am J Hum Genet. 2002. PMID: 11709755 Free PMC article.

3

Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.

Glas AS, Hollema H, Nap RE, Plukker JT. Glas AS, et al. Among authors: hollema h. Cancer. 2002 Apr 15;94(8):2211-6. doi: 10.1002/cncr.10445. Cancer. 2002. PMID: 12001119 Free article.

4

An oncological view on the blood-testis barrier.

Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG. Bart J, et al. Among authors: hollema h. Lancet Oncol. 2002 Jun;3(6):357-63. doi: 10.1016/s1470-2045(02)00776-3. Lancet Oncol. 2002. PMID: 12107023 Review.

5

Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas.

Meijer WG, Copray SC, Hollema H, Kema IP, Zwart N, Mantingh-Otter I, Links TP, Willemse PH, de Vries EG. Meijer WG, et al. Among authors: hollema h. Clin Chem. 2003 Apr;49(4):586-93. doi: 10.1373/49.4.586. Clin Chem. 2003. PMID: 12651811

6

Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.

Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG, de Jong S. Koornstra JJ, et al. Among authors: hollema h. J Pathol. 2003 Jul;200(3):327-35. doi: 10.1002/path.1364. J Pathol. 2003. PMID: 12845629

7

Gynecologic screening in hereditary nonpolyposis colorectal cancer.

Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, van der Zee AG. Rijcken FE, et al. Among authors: hollema h. Gynecol Oncol. 2003 Oct;91(1):74-80. doi: 10.1016/s0090-8258(03)00371-8. Gynecol Oncol. 2003. PMID: 14529665

8

Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.

Wisman GB, Hollema H, Helder MN, Knol AJ, Van der Meer GT, Krans M, De Jong S, De Vries EG, Van der Zee AG. Wisman GB, et al. Among authors: hollema h. Int J Oncol. 2003 Nov;23(5):1451-9. doi: 10.3892/ijo.23.5.1451. Int J Oncol. 2003. PMID: 14532990

9

Hyperplastic polyps in hereditary nonpolyposis colorectal cancer.

Rijcken FE, van der Sluis T, Hollema H, Kleibeuker JH. Rijcken FE, et al. Among authors: hollema h. Am J Gastroenterol. 2003 Oct;98(10):2306-11. doi: 10.1111/j.1572-0241.2003.07629.x. Am J Gastroenterol. 2003. PMID: 14572584

10

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.

Berends MJ, Wu Y, Sijmons RH, van der Sluis T, Ek WB, Ligtenberg MJ, Arts NJ, ten Hoor KA, Kleibeuker JH, de Vries EG, Mourits MJ, Hollema H, Buys CH, Hofstra RM, van der Zee AG. Berends MJ, et al. Among authors: hollema h. J Clin Oncol. 2003 Dec 1;21(23):4364-70. doi: 10.1200/JCO.2003.04.094. J Clin Oncol. 2003. PMID: 14645426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters